fda warning letter hims compounded semaglutide september 2025 takes aim at & Hers, weight loss drugs in new advertising blitz From Crackdown to Collaboration: FDA

Common claims include failure to warn about the Ozempic and Mounjaro side effects and making false claims about the safety of these drugs

Why "research chemical" sellers are a red flag Compounds marketed online as research chemicals bypass pharmaceutical manufacturing standards

Can infusion therapy help with recovery

Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use

The results showed that liraglutide had a modest positive effect on improving motor function and performed well in terms of safety and tolerability, although there were some manageable gastrointestinal side effects